A stable panel comprising 18 urinary proteins in the human healthy population

Proteomics

Volumn 12, Issue 7, 2012, Pages 1059-1072

  He, Weifeng ^a   Huang, Chibing ^a   Luo, Gaoxing ^a   Prà, Ilaria Dal ^b   Feng, Jiayu ^a   Chen, Wei ^c   Ma, Li ^a   Wang, Ying ^a   Chen, Xiwei ^a   Tan, Jiangling ^a   Zhang, Xiaorong ^a   Armato, Ubaldo ^b   Wu, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF VERONA   (Italy)

^c AGILENT TECHNOLOGIES   (China)

Author keywords

Biomarker; Biomedicine; Dynamic variation; Mass spectrometry; Urinary proteomics

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; PROTEOMICS; URINALYSIS;

ADOLESCENT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLUSTER ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; PROTEINURIA; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84859953620     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100400     Document Type: Article

References (64)

1. Decramer, S., Gonzalez de Peredo, A., Breuil, B., Mischak, H. et al., Urine in clinical proteomics. Mol. Cell Proteomics 2008, 7, 1850-1862.
2. Goodison, S., Rosser, C. J., Urquidi, V., Urinary proteomic profiling for diagnostic bladder cancer biomarkers. Expert Rev. Proteomics 2009, 6, 507-514.
3. Vasudev, N. S., Sim, S., Cairns, D. A., Ferguson, R. E. et al., Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma. Br. J. Cancer 2009, 101, 1175-1182.
4. Ling, X. B., Sigdel, T. K., Lau, K., Ying, L. et al., Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J. Am. Soc. Nephrol. 2010, 21, 646-653.
5. Jia, X., Gan, C., Xiao, K., He, W. et al., Detection of urinary biomarkers for early diagnosis of acute renal allograft rejection by proteomic analysis. Proteomics Clin. Appl. 2009, 3, 694-704.
6. Zhou, H., Pisitkun, T., Aponte, A., Yuen, P. S. et al., Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006, 70, 1847-1857.
7. Devarajan, P., Proteomics for biomarker discovery in acute kidney injury. Semin. Nephrol. 2007, 27, 637-651.
8. Vilasi, A., Cutillas, P. R., Maher, A. D., Zirah, S. F. et al., Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am. J. Physiol. Renal. Physiol. 2007, 293, F456-F467.
9. Jain, S., Rajput, A., Kumar, Y., Uppuluri, N. et al., Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J. Assoc. Physicians India 2005, 53, 513-520.
10. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
11. Marimuthu, A., O'Meally, R. N., Chaerkady, R., Subbannayya, Y., Nanjappa, V. et al., A comprehensive map of the human urinary proteome. J. Proteome. Res. 2011, 10, 2734-2743.
12. Li, Q. R., Fan, K. X., Li, R. X., Dai, J. et al., A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine. Rapid Commun. Mass Spectrom. 2010, 24, 823-832.
13. Kentsis, A., Monigatti, F., Dorff, K., Campagne, F. et al., Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteomics Clin. Appl. 2009, 3, 1052-1061.
14. Nagaraj, N., Mann, M., Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J. Proteome. Res. 2011, 10, 637-645.
15. Shao, C., Wang, Y., Gao, Y., Applications of urinary proteomics in biomarker discovery. Sci. China Life Sci. 2011, 54, 409-417.
16. Thongboonkerd, V., Chutipongtanate, S., Kanlaya, R., Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J. Proteome. Res. 2006, 5, 183-191.
17. Sun, W., Chen, Y., Li, F., Zhang, L. et al. Dynamic urinary proteomic analysis reveals stable proteins to be potential biomarkers. Proteomics Clin. Appl. 2009, 3, 370-382.
18. Oh, J., Pyo, J. H., Jo, E. H., Hwang, S. I. et al., Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 2004, 4, 3485-3497.
19. Pieper, R., Gatlin, C. L., McGrath A. M., Makusky, A. J. et al., Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4, 1159-1174.
20. Foster, L. J., De Hoog, C. L., Mann, M., Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl. Acad. Sci. USA 2003, 100, 5813-5818.
21. Horth, P., Miller, C. A., Preckel, T., Wenz, C., Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis. Mol. Cell. Proteomics 2006, 5, 1968-1974.
22. Zhang, Y., Adachi, J., Olsen, J. V., Shi, R. et al., Max-Planck Unified (MAPU): Max-Planck Unified database of organellar, cellular, tissue and body fluid proteomes. Nucleic Acids Res. 35, D771-D779.
23. Pisitkun, T., Shen, R. F., Knepper, M. A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 2004, 101, 13368-13373.
24. Gonzales, P. A., Pisitkun, T., Hoffert, J. D., Tchapyjnikov, D. et al., Large-scale proteomics and phosphoproteomics of urinary exosomes. J. Am. Soc. Nephrol. 2009, 20, 363-379.
25. Wu, J., Wang, N., Wang, J., Xie, Y. et al., Identification of a uromodulin fragment for diagnosis of IgA nephropathy. Rapid Commun. Mass Spectrom. 2010, 24, 1971-1978.
26. Quintana, L. F., Campistol, J. M., Alcolea, M. P., Banon-Maneus, E. et al., Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol. Cell Proteomics 2009, 8, 1658-1673.
27. Kistler, A. D., Mischak, H., Poster, D., Dakna, M. et al., Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2009, 76, 89-96.
28. Lau, W. H., Leong, W. S., Ismail, Z., Gam, L. H., Qualification and application of an ELISA for the determination of Tamm Horsfall protein (THP) in human urine and its use for screening of kidney stone disease. Int. J. Biol. Sci. 2008, 4, 215-222.
29. Wai-Hoe, L., Wing-Seng, L., Ismail, Z., Lay-Harn, G., Proteomics and detection of uromodulin in first-time renal calculi patients and recurrent renal calculi patients. Appl. Biochem. Biotechnol. 2009, 159, 221-232.
30. Riaz, S., Alam, S. S., Srai, S. K., Skinner, V. et al., Proteomic identification of human urinary biomarkers in diabetes mellitus type 2. Diabetes Technol. Ther. 2010, 12, 979-988.
31. Skipworth, R. J., Stewart, G. D., Bhana, M., Christie, J. et al., Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine. Int. J. Oncol. 2010, 36, 973-982.
32. Aregger, F., Pilop, C., Uehlinger, D. E., Brunisholz, R. et al., Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury. J. Thorac. Cardiovasc. Surg. 2010, 139, 692-700.
33. Gao, Y., Wu, K., Xu, Y., Zhou, H. et al., Characterization of acute renal allograft rejection by human serum proteomic analysis. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2009, 29, 585-591.
34. Vojtova, L., Zima, T., Tesar, V., Michalova, J. et al., Study of urinary proteomes in Anderson-Fabry disease. Ren. Fail. 2010, 32, 1202-1209.
35. Ramirez-Llanelis, R., Llop, E., Ventura, R., Segura, J., Gutierrez-Gallego, R., Can glycans unveil the origin of glycoprotein hormones?-human chorionic gonadotrophin as an example. J. Mass. Spectrom. 2008, 43, 936-948.
36. Vakhrushev, S. Y., Mormann, M., Peter-Katalinic, J., Identification of glycoconjugates in the urine of a patient with congenital disorder of glycosylation by high-resolution mass spectrometry. Proteomics 2006, 6, 983-992.
37. Heo, S. H., Lee, S. J., Ryoo, H. M., Park, J. Y., Cho, J. Y., Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 2007, 7, 4292-4302.
38. Chen, C. P., Chen, R. L., Preston, J. E., Age-related increase of prostaglandin D(2) synthase concentration and glycation in ovine cerebrospinal fluid. Exp. Gerontol. 2009, 44, 639-645.
39. Qiu, Y., Patwa, T. H., Xu, L., Shedden, K. et al., Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J. Proteome. Res. 2008 7, 1693-1703.
40. Gupta, N., Shankernarayan, N. P., Dharmalingam, K., Alpha1-acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy. J. Med. Microbiol. 2010, 59, 400-407.
41. Saldova, R., Wormald, M. R., Dwek, R. A., Rudd, P. M., Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis. Markers. 2008, 25, 219-232.
42. Imre, T., Kremmer, T., Heberger, K., Molnar-Szollosi, E. et al., Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals. J. Proteomics 2008, 71, 186-197.
43. Saldova, R., Royle, L., Radcliffe, C. M., Abd Hamid, U. M. et al., Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007, 17, 1344-1356.
44. Devarajan, P., Krawczeski, C. D., Nguyen, M. T., Kathman, T. et al., Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children. Am. J. Kidney Dis. 2010, 56, 632-642.
45. Goo, Y. A., Tsai, Y. S., Liu, A. Y., Goodlett, D. R., Yang, C. C., Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: a pilot study. Int. Braz. J. Urol. 2010, 36, 464-478; discussion 478-469, 479.
46. Komaba, H., Fukagawa, M., Fetuin-mineral complex: a new potential biomarker for vascular calcification? Kidney Int. 2009, 75, 874-876.
47. Coen, G., De Paolis, P., Ballanti, P., Pierantozzi, A. et al., Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23. J. Nephrol. 2011, 24, 313-321.
48. Yi, J. K., Chang, J. W., Han, W., Lee, J. W. et al., Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 1357-1364.
49. Yokota, H., Hiramoto, M., Okada, H., Kanno, Y. et al., Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria. Mol. Cell. Proteomics 2007, 6, 738-744.
50. Taneja, S., Sen, S., Gupta, V. K., Aggarwal, R., Jameel, S., Plasma and urine biomarkers in acute viral hepatitis E. Proteome Sci. 2009, 7, 39.
51. Bolt, H. M., Lammert, M., Selinski, S., Bruning, T., Urinary alpha1-microglobulin excretion as biomarker of renal toxicity in trichloroethylene-exposed persons. Int. Arch. Occup. Environ. Health 2004, 77, 186-190.
52. Szajda, S. D., Snarska, J., Jankowska, A., Roszkowska-Jakimiec, W. et al., Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Hepatogastroenterology 2008, 55, 388-393.
53. Vanden Heuvel, G. B., CD14 : a candidate biomarker for the prognosis of polycystic kidney disease. Kidney Int. 2010, 78, 537-538.
54. Cheng, H. L., Huang, H. J., Ou, B. Y., Chow, N. H. et al., Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labeling. Proteomics Clin. Appl. 2011, 5, 121-132.
55. Soler-Garcia, A. A., Johnson, D., Hathout, Y., Ray, P. E., Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseases. Clin. J. Am. Soc. Nephrol. 2009, 4, 763-771.
56. Abdullah-Soheimi, S. S., Lim, B. K., Hashim, O. H., Shuib, A. S., Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin. Proteome Sci. 2010, 8, 58-64.
57. Nakayama, H., Echizen, H., Gomi, T., Shibuya, Y. et al., Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage? Ther. Drug. Monit. 2009, 31, 126-130.
58. Wu, T., Fu, Y., Brekken, D., Yan, M. et al., Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J. Immunol. 2010, 184, 2183-2193.
59. Yoshikawa, R., Wada, J., Seiki, K., Matsuoka, T. et al., Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients. Diabetes Res. Clin. Pract. 2007, 76, 358-367.
60. Rajpal, R., Dowling, P., Meiller, J., Clarke, C. et al., A novel panel of protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patients. Proteomics 2011, 11, 1391-1402.
61. Bai, S., Liu, S., Guo, X., Qin, Z. et al., Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients. Mol. Vis. 2009, 15, 1638-1648.
62. Qin, Z., Qin, Y., Liu, S., Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cell. Mol. Neurobiol. 2009, 29, 203-210.
63. Ahn, J. M., Kim, B. G., Yu, M. H., Lee, I. K., Cho, J. Y., Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS/MS. Proteomics Clin. Appl. 2010, 4, 644-653.
64. Piyaphanee, N., Ma, Q., Kremen, O., Czech, K. et al., Discovery and initial validation of alpha 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome. Proteomics Clin. Appl. 2011, 5, 334-342.